PANTHERx Sells to Centene

We represented PANTHERx, a specialty pharmacy specializing in orphan drugs and rare diseases, in its sale to Centene Corporation, a diversified, multi-national healthcare enterprise that provides a portfolio of services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Terms of the transaction were not disclosed.

You Also May Be Interested In:

  • Representation of New Harbor Capital’s portfolio company Psych Associates of Maryland, the largest outpatient mental health group in Maryland, in its acquisition of Comprehensive Behavioral Health, a leading multidisciplinary mental health treatment provider. Terms of the transaction were not disclosed.

    We represented New Harbor Capital's portfolio company Psych Associates of Maryland, the largest outpatient mental health group in Maryland, in...
  • Representation of NVision Eye Centers, one of the largest providers of LASIK and cataract surgery in the U.S, in its acquisition of Turner Eye Institute, a LASIK and other eye surgery center. Terms of the transaction were not disclosed.

    We represented NVision Eye Centers, one of the largest providers of LASIK and cataract surgery in the U.S, in its...
  • Representation of Haven Behavioral Health, who operates acute care behavioral hospitals across the country, in its acquisition of WW IOP, LLC, a Boise, ID outpatient mental health clinic. Terms of the transaction were not disclosed.

    We represented Haven Behavioral Health, who operates acute care behavioral hospitals across the country, in its acquisition of WW IOP,...